2 mins read
Baricitinib and casirivimab-imdevimab recommended by WHO to treat COVID-19 patients
On Friday 14’th January, the World Health Organization recommended the use of two new drugs Baricitinib and Casirivimab-Imdevimab for the […]
January 18, 2022
2 mins read
Pharmaceutical wholesale distributors in the Health sector
The pharmaceutical industry is changing rapidly. Due to increasing chronic diseases and after the Covid-19 outbreak, there came a massive […]
October 25, 2021
2 mins read
India helped Brazil in the hour of need during Covid
In the peak time of the Covid pandemic outbreak, countries like Brazil sought a shortage of essential medicines and medical […]
October 21, 2021
2 mins read
Third-party pharmaceutical manufacturing
Third-party pharma manufacturing facilitates a bridge between the manufacturer and the organization/ hospitals in need of a product with standard […]
October 20, 2021
2 mins read
Ikris Pharmaceutical in Brazil Health sector
We, Ikris Pharma Network are International pharmaceutical distributors from India. We supply products to all the people involved in the […]
October 20, 2021
2 mins read
Role of IKRIS Pharma in Healthcare!
Ikris Pharma Network was founded in 2014 and is based in Noida, India. We are one of the most reliable […]
August 18, 2021
2 mins read
Contract Manufacturing/Private Label Manufacturing
Due to the impact of COVID-19, the pharmaceutical sector sought contract manufacturing in a big way. Its growth from USD […]
July 28, 2021
2 mins read
Reference Listed Drug & its Sourcing
In FDA jargon, RLD stands for Reference Listed Drug. Let’s throw a couple of more familiar acronyms in the mix: […]
July 22, 2021
2 mins read
Ikris Pharma Network- A Generic Medication Supplier
The demand for generic medicines is increasing at the global level and pharmaceutical companies are realising the huge potential this […]
July 19, 2021
4 mins read
Ribociclib plus Endocrine Therapy demonstrated improved overall survival in advanced HR+/HER2- Breast Cancer
According to findings from an exploratory analysis of the Phase-III MONALEESA-7 trial presented during the 2021 ESMO Breast Cancer Virtual […]
June 9, 2021Featured Post
3 mins read
Cervical Cancer and Its Preventive Measures
Key Highlights: Cervical cancer is the 4’th most frequently occurring cancer among women across the world, with an estimated 604000 […]
ikrisuser
January 19, 2023
2 mins read
Myalgia is Regarded as ‘Top’ Symptom for COVID-19 and is Now Widely Reported
Since the onset of the 2019 Novel Coronavirus Or 2019-nCoV, so many new variants of the coronavirus disease have emerged […]
ikrisuser
January 18, 2023< 1 min read
FDA approved 2022: Biologics
Biological products include various products such as vaccines, blood and blood components, allergenic, somatic cells, gene therapy, tissues, and recombinant […]
ikrisuser
January 18, 2023
3 mins read
The Global Strategy of WHO for Elimination of Cervical Cancer
What is Cervical Cancer: Cervical cancer mainly occurs in the Cervix. The cervix is a kind of hollow cylinder that […]
ikrisuser
January 18, 2023
3 mins read
New Rare Disease Policy: India
The definition of Rare diseases differs from one geographical region to another. Rare diseases are such diseases that are rare, […]
ikrisuser
January 16, 2023
3 mins read
3.7M Treatment Courses of PAXLOVID are Planned for Delivery by Early 2023 to Help Combat COVID-19
According to Pfizer, they have reached an agreement with the U.S. Government for the purchase of an additional 3.7 Million […]
ikrisuser
January 15, 2023
4 mins read
Which Oral Medicine is Best for Treating COVID-19? Molnupiravir Or Paxlovid
Key Highlights: Molnupiravir (Lagevrio) and Paxlovid (consists of a couple of medications: nirmatrelvir and ritonavir) are 2 oral antiviral treatments […]
ikrisuser
January 15, 2023
3 mins read
The Use of Antibiotic in COVID Patients
COVID-19 is an infectious disease that is typically defined as an illness caused by a novel coronavirus also called severe […]
ikrisuser
January 15, 2023
2 mins read
New Covid-19, Omicron Variant : XBB 1.5
The new variant of SARS Covid-19 has increased global tensions among nations as the cases are increasing daily. Many Cases […]
ikrisuser
January 11, 2023
2 mins read
XBB.1.5- A Subvariant of Omicron is Likely to be the Next Potential Threat
The COVID outbreak continues to be a potential threat to global public health. The cases of COVID-19 have been climbing […]
ikrisuser
January 10, 2023Popular Post
Third party pharmaceutical manufacturer
Third-party pharmaceutical manufacturing
- October 20, 2021
- 2 mins read
pharmaceutical wholesale distributors
Pharmaceutical wholesale distributors in the Health sector
- October 25, 2021
- 2 mins read
Black Fungus
How Risky is Black Fungus? What are the Symptoms and Treatment?
- May 24, 2021
- 4 mins read
We Offer You
Partnership
We love to partner with brands and products that we believe in. If you feel that your company shares values and would benefit our readers, we would love to talk about working together.
Learn More
